The hormonal effect of fibroblast growth factor 19 on the intestinal adaptation in pediatric short bowel syndrome: an in vitro study using patients-derived enteroids

In brief

This study investigates how fibroblast growth factor 19 (FGF19) influences intestinal adaptation in pediatric short bowel syndrome using patient-derived enteroid models. The research aims to understand hormonal mechanisms that could enhance gastrointestinal recovery in children with SBS, potentially informing future therapeutic strategies.

• FGF19 is a novel hormonal target for promoting intestinal adaptation in pediatric short bowel syndrome patients.
• Patient-derived enteroids provide a clinically relevant in vitro model to study intestinal adaptation mechanisms.
• Understanding FGF19's role may lead to new therapeutic strategies for restoring GI function in pediatric SBS.
• Hormonal modulation of intestinal adaptation represents an emerging approach beyond traditional nutritional support.

Written by the GCMD Library team from the article.